Ardelyx Reports Clinical Progress and Fourth Quarter and Full Year 2016 Financial Results

Go back to Ardelyx Reports Clinical Progress and Fourth Quarter and Full Year 2016 Financial Results

Ardelyx (ARDX) Reports In-Line Q4 EPS

February 17, 2017 4:08 PM EST

Ardelyx (NASDAQ: ARDX) reported Q4 EPS of ($0.66), in-line with the analyst estimate of ($0.66).

For earnings history and earnings-related data on Ardelyx (ARDX) click here.

... More